ANIP
Price
$68.38
Change
-$0.57 (-0.83%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
1.43B
15 days until earnings call
ORGO
Price
$4.44
Change
+$0.11 (+2.54%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
374.78M
14 days until earnings call
Ad is loading...

ANIP vs ORGO

Header iconANIP vs ORGO Comparison
Open Charts ANIP vs ORGOBanner chart's image
ANI Pharmaceuticals
Price$68.38
Change-$0.57 (-0.83%)
Volume$4.42K
Capitalization1.43B
Organogenesis Holdings
Price$4.44
Change+$0.11 (+2.54%)
Volume$29.4K
Capitalization374.78M
ANIP vs ORGO Comparison Chart
Loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIP vs. ORGO commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a StrongBuy and ORGO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ANIP: $68.95 vs. ORGO: $4.33)
Brand notoriety: ANIP and ORGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANIP: 66% vs. ORGO: 141%
Market capitalization -- ANIP: $1.43B vs. ORGO: $374.78M
ANIP [@Pharmaceuticals: Other] is valued at $1.43B. ORGO’s [@Pharmaceuticals: Other] market capitalization is $374.78M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 0 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • ANIP’s FA Score: 0 green, 5 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, both ANIP and ORGO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 5 TA indicator(s) are bullish while ORGO’s TA Score has 5 bullish TA indicator(s).

  • ANIP’s TA Score: 5 bullish, 4 bearish.
  • ORGO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ANIP is a better buy in the short-term than ORGO.

Price Growth

ANIP (@Pharmaceuticals: Other) experienced а -0.86% price change this week, while ORGO (@Pharmaceuticals: Other) price change was +0.23% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.98%. For the same industry, the average monthly price growth was -5.65%, and the average quarterly price growth was -11.39%.

Reported Earning Dates

ANIP is expected to report earnings on Aug 06, 2025.

ORGO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.98% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIP($1.43B) has a higher market cap than ORGO($375M). ANIP has higher P/E ratio than ORGO: ANIP (79.85) vs ORGO (70.25). ORGO YTD gains are higher at: 35.312 vs. ANIP (24.729). ANIP has higher annual earnings (EBITDA): 107M vs. ORGO (36M). ANIP has more cash in the bank: 221M vs. ORGO (104M). ORGO has less debt than ANIP: ORGO (119M) vs ANIP (286M). ANIP has higher revenues than ORGO: ANIP (487M) vs ORGO (433M).
ANIPORGOANIP / ORGO
Capitalization1.43B375M381%
EBITDA107M36M297%
Gain YTD24.72935.31270%
P/E Ratio79.8570.25114%
Revenue487M433M112%
Total Cash221M104M213%
Total Debt286M119M240%
FUNDAMENTALS RATINGS
ANIP vs ORGO: Fundamental Ratings
ANIP
ORGO
OUTLOOK RATING
1..100
1975
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
4293
SMR RATING
1..100
9190
PRICE GROWTH RATING
1..100
4241
P/E GROWTH RATING
1..100
918
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORGO's Valuation (74) in the Financial Conglomerates industry is in the same range as ANIP (94) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's Profit vs Risk Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for ORGO (93) in the Financial Conglomerates industry. This means that ANIP’s stock grew somewhat faster than ORGO’s over the last 12 months.

ORGO's SMR Rating (90) in the Financial Conglomerates industry is in the same range as ANIP (91) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to ANIP’s over the last 12 months.

ORGO's Price Growth Rating (41) in the Financial Conglomerates industry is in the same range as ANIP (42) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to ANIP’s over the last 12 months.

ORGO's P/E Growth Rating (8) in the Financial Conglomerates industry is significantly better than the same rating for ANIP (91) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew significantly faster than ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPORGO
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
73%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 16 days ago
70%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEPSX25.70N/A
N/A
Principal Glb Emerging Markets R5
TWCCX50.64N/A
N/A
American Century Ultra® C
SGNFX41.34N/A
N/A
Sparrow Growth No-Load
VIESX15.41N/A
N/A
Virtus KAR Emerging Markets Small-Cap I
HGHVX40.08N/A
N/A
Hartford Healthcare R6

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with ORGO. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
+1.40%
ORGO - ANIP
44%
Loosely correlated
+2.85%
PRGO - ANIP
39%
Loosely correlated
+1.85%
DRRX - ANIP
38%
Loosely correlated
-0.93%
SNDL - ANIP
31%
Poorly correlated
+2.21%
PRPH - ANIP
29%
Poorly correlated
+13.25%
More

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with PRGO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
+2.85%
PRGO - ORGO
47%
Loosely correlated
+1.85%
ANIP - ORGO
44%
Loosely correlated
+1.40%
AMRX - ORGO
32%
Poorly correlated
+1.68%
ACET - ORGO
29%
Poorly correlated
+2.34%
AMPH - ORGO
27%
Poorly correlated
+1.83%
More